Blowing Conch Shell Tied to Improved Obstructive Sleep Apnea Measures
By Lori Solomon HealthDay Reporter

MONDAY, Aug. 11, 2025 -- Respiratory muscle training through shankh (conch shell) blowing improves outcomes in individuals with obstructive sleep apnea (OSA), according to a study published online Aug. 10 in ERJ Open Research.
Krishna K. Sharma, M.D., from Eternal Heart Care Centre and Research Institute in Jaipur, India, and colleagues randomly assigned individuals with moderate OSA to a sham procedure group (deep breathing exercise; 16 patients) or to a shankh-blowing group (14 patients) for six months.
The researchers found that participants in the intervention group showed greater improvement in sleepiness, with a 34 percent reduction in the Epworth Sleepiness scale (ESS; change, −5.0 points), as well as a significant change in the mean difference of the ESS score (−4.69 points) between the groups. At six months, sleep quality (Pittsburgh Quality of Sleep Index score [PSQI]; change, −1.8 points) and the apnea-hypopnea index (AHI; change, −4.4 events/hour) were improved in the intervention group. The mean between-group difference was −3.1 points for the PSQI score and −5.62 events/hour for the AHI.
"The way the shankh is blown is quite distinctive. It involves a deep inhalation followed by a forceful, sustained exhalation through tightly pursed lips," Sharma said in a statement. "This action creates strong vibrations and airflow resistance, which likely strengthens the muscles of the upper airway, including the throat and soft palate -- areas that often collapse during sleep in people with OSA."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-12 06:00
Read more

- FDA Approves First Cream for Treating Chronic Hand Eczema, Anzupgo
- HHS Plans to Reform Organ Procurement Protocols
- Lilly's Oral GLP-1, Orforglipron, Delivers Weight Loss of Up To an Average of 27.3 lbs in First of Two Pivotal Phase 3 Trials in Adults with Obesity
- Good Weight-Loss Diets Avoid Processed Foods, Study Finds
- Survey Reveals Public Has Negative Perceptions of Physicians Using AI
- AMA, AAP, IDSA Among Organizations Disinvited From CDC Vaccine Workgroups
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions